Chitosan arrests bleeding in major hepatic injuries with clotting dysfunction: an <i>in vivo</i> experimental study in a model of hepatic injury in the presence of moderate systemic heparinisation

Abstract

The results support the evidence that chitosan-derived products act independently of classical clotting pathways and should be effective in patients who suffer major liver injury even in the presence of clotting dysfunctions.